Summit Wealth Group (Colorado)’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.4M Buy
3,803
+1,581
+71% +$1.87M 0.28% 50
2026
Q2
$2.67M Buy
2,222
+183
+9% +$187K 0.22% 57
2026
Q1
$1.88M Buy
2,039
+101
+5% +$102K 0.2% 68
2025
Q4
$2.08M Buy
1,938
+221
+13% +$211K 0.28% 53
2025
Q3
$922K Buy
1,717
+943
+122% +$702K 0.1% 178
2025
Q2
$603K Buy
+774
New +$601K 0.15% 118

Other funds holding LLY

Summit Wealth Group (Colorado)'s LLY Position: Q3 2026 in Review

Summit Wealth Group (Colorado) increased its Eli Lilly (LLY) stake by 71% in Q3 2026, buying an estimated $1.87M and bringing the position to 3,803 shares worth $4.4M. The position accounts for 0.28% of the portfolio, ranked #50.

Summit Wealth Group (Colorado) first reported a position in LLY in Q2 2025 and has held it in 6 quarters since. 3,244 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Summit Wealth Group (Colorado) held 3,803 shares of Eli Lilly worth $4.4M as of Q3 2026.
  • Summit Wealth Group (Colorado) bought 1,581 Eli Lilly shares in Q3 2026, an estimated $1.87M.
  • Eli Lilly made up 0.28% of Summit Wealth Group (Colorado)'s portfolio in Q3 2026, its #50 holding.
  • Summit Wealth Group (Colorado) first reported a position in Eli Lilly in Q2 2025 and has held it in 6 quarters since.
  • 3,244 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Summit Wealth Group (Colorado)'s 13F filing for Q3 2026, filed 29 Oct 2026.